Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Join SI Premium – FREE
Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.77), $0.11 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $20.87 million versus the consensus estimate of $20.16 million.
For earnings history and earnings-related data on Kura Oncology (KURA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple announced foldable iPhone Duo, starting at $1,999
- Apple announces AirPods 5
- Academy Sports surges on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
